Next Century Growth Investors’s AMAG Pharmaceuticals AMAG Stock Holding History

Next Century Growth Investors’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-342,623	Closed	-$13.6M	–	188
2015 Q3	$13.6M	Buy	342,623 +44,848	+15%	+$2.78M	0.57%	55
2015 Q2	$20.6M	Buy	297,775 +13,287	+5%	+$836K	0.71%	43
2015 Q1	$15.6M	Buy	+284,488	New	+$13.6M	0.55%	63

Other funds holding AMAG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Next Century Growth Investors's AMAG Position: Q4 2015 in Review

Next Century Growth Investors sold out of AMAG Pharmaceuticals (AMAG) in Q4 2015, closing a stake of 342,623 shares — an estimated $13.6M sold.

Next Century Growth Investors first reported a position in AMAG in Q1 2015 and held it in 3 quarters. The position peaked at $20.6M in Q2 2015. 172 funds tracked by Wall St. Rank hold AMAG as of Q4 2015.

Next Century Growth Investors reported no remaining AMAG Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Next Century Growth Investors sold 342,623 AMAG Pharmaceuticals shares in Q4 2015, an estimated $13.6M.
Next Century Growth Investors first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 3 quarters.
Next Century Growth Investors's AMAG Pharmaceuticals position peaked at $20.6M in Q2 2015.
172 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2015.

Based on Next Century Growth Investors's 13F filing for Q4 2015, filed 12 Feb 2016.